Filter
4918
Filtered Results: 4918
Text search:
medcines
Featured
Recommendations
492
New Publications
1403
Language
Document type
No document type
2594
Studies & Reports
800
Guidelines
681
Manuals
257
Strategic & Response Plan
200
Fact sheets
138
Training Material
88
Situation Updates
68
Resource Platforms
28
Brochures
26
Infographics
22
Online Courses
11
Videos
5
Countries / Regions
India
248
Global
191
Kenya
151
South Africa
114
Ethiopia
110
Uganda
109
Sierra Leone
97
Nepal
96
Liberia
92
Africa
91
Nigeria
87
Western and Central Europe
83
Bangladesh
76
Myanmar / Burma
75
Malawi
74
Ukraine
73
Ghana
72
Tanzania
72
Zambia
71
Latin America and the Carribbean
65
Rwanda
59
Syria
56
Namibia
49
Congo, Democratic Republic of
47
Philippines
42
Venezuela
41
Zimbabwe
39
Eastern Europe
37
South–East Asia Region
36
Haiti
33
Mozambique
30
Asia
29
Guinea
27
West and Central Africa
27
Burkina Faso
26
Indonesia
26
Cambodia
24
East and Southern Africa
24
Lesotho
23
Senegal
23
Middle East and North Africa
23
Russia
23
Yemen
23
Botswana
22
South Sudan
22
Brazil
19
Germany
18
Eastern Europe and Central Asia
17
Madagascar
16
Eswatini/ Swaziland
16
Cameroon
15
Pakistan
15
Sudan
13
Benin
12
Afghanistan
12
Western Pacific Region
12
Tajikistan
10
Colombia
10
Central African Republic
10
Somalia
10
Paraguay
9
Lebanon
9
Moldova
9
Mali
9
Thailand
8
Georgia
8
Peru
7
North America
7
Vietnam
7
North Macedonia
6
Laos
6
Jordan
6
Côte d’Ivoire / Ivory Coast
6
Albania
5
Kyrgyzstan
5
Southern Africa
5
Bolivia
5
Argentina
5
Palestine
5
Poland
5
Iraq
5
Mexico
4
El Salvador
4
Turkey
4
China
4
Iran
4
Niger
4
Hungary
4
United Kingdom
4
Sri Lanka
4
Libya
4
Bhutan
4
Ecuador
4
Serbia
3
Kazakhstan
3
Fiji
3
Morocco
3
Armenia
3
USA
3
Saudi Arabia
3
Jamaica
3
Mauritius
3
Papua New Guinea
3
Egypt
3
Romania
3
Angola
3
Timor Leste/ East Timor
2
Australia
2
Gambia
2
Chile
2
Canada
2
Uzbekistan
2
Qatar
2
Bulgaria
2
Guinea-Bissau
2
Gabon
2
Turkmenistan
2
Japan
2
Tunisia
2
Belarus
2
Chad
2
Switzerland
1
Togo
1
Congo-Brazzaville
1
Burundi
1
Malaysia
1
Mongolia
1
Lithuania
1
Uruguay
1
Denmark
1
France
1
Maldives
1
Norway
1
Portugal
1
Spain
1
Israel
1
Latvia
1
Nicaragua
1
Djibouti
1
Slovakia
1
Greece
1
Honduras
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2006
Clinical Guidelines
435
Public Health
293
Women & Child Health
204
Key Resources
119
Capacity Building
90
Pharmacy & Technologies
56
Annual Report MEDBOX
2
Toolboxes
COVID-19
384
HIV
381
TB
299
AMR
294
Mental Health
281
Pharmacy
254
NCDs
153
Caregiver
131
Conflict
130
Ebola
113
Disability
107
NTDs
98
Rapid Response
97
Refugee
93
Planetary Health
92
Global Health Education
79
Natural Hazards
51
Health Financing Toolbox
41
Zika
20
Cholera
16
Polio
12
Specific Hazards
11
Social Ethics
7
Health Financing
2
Typhoon
1
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB care in over 130
countries, providing treatments to over 30 million people with TB and procuring
...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epide...
2nd edition. A Guide to Managing Medicines for All Health Workers. Available for purchase via following link https://www.twn.my/title2/books/HAI.htm
Where there are no trained pharmacists serving communities, other categories of health workers are called upon to order, buy, store, dispense and ad...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...
This guideline covers making people aware of how to correctly use antimicrobial medicines (including antibiotics) and the dangers associated with their overuse and misuse. It also includesmeasures to prevent and control infection that can stop people needing antimicrobials or spreadinginfection to o...
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro...
Global actions to reduce antimicrobial resistance (AMR) include optimising the use of antimicrobial medicines in human and animal health. In countries with weak healthcare regulation, this requires a greater understanding of the drivers of antibiotic use from the perspective of providers and consume...
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
Please complete the section below. Bring all your medicines and inhalers along with a complete list to doctor’s office visits. Think about your ability to perform these activities on a typical “green” day. Place one check mark in each column. In the last (blank) column write in an activity you...
Using an inhaler is the most common and effective way of taking asthma medicines. If you’re NOT using your inhaler correctly, you might not be getting the full dose of medicine your doctor or asthma nurse prescribed because the medicine can’t reach your
lungs. Instead it might be hitting the ba...
It is estimated that around 2 billion people worldwide do not have access to essential medicines. Access to medicines in the Eastern Mediterranean Region varies among countries, depending on their income level and allocation of domestic resources to medicine and vaccine procurement. Access to safe a...
Early-warning indicators to prevent stock-outs and overstocking of antiretroviral, antituberculosis and antimalaria medicines.
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those ...
The objective of this book is to provide health workers with easily accessible information on important aspects of the medicines commonly used at primary care level in Zimbabwe. Medicines are a crucial part of the management of most of our patients, yet many medicines are potentially dangerous if no...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and ...
Antimicrobial resistance (AMR) occurs when disease-causing pathogens are able to withstand the killing or suppressing power of antimicrobial medicines. This phenomenon increases the global burden of infectious diseases and strains health systems.This course aims to improve the learner's awareness an...
